SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization

Recruiting now

Conditions studied: Prostate Cancer, Advanced Cancer

In brief

The investigators will study SPECT imaging of radiopharmaceutical therapies given as standard of care or as part of other compatible research protocols. The goal is to validate the quantitative SPECT image reconstruction methods developed in this proposal, and to investigate the relation between dosimetry calculated from SPECT images and the outcomes. Patients will be recruited for SPECT/CT imaging during treatment. This is an observational study no additional new drugs or activities will be administrated. The investigators will perform SPECT imaging on a total of 80 patients (\~20 each from year 2 to year 5). Each participant will be imaged 3 times after the first and last cycles of planned radiopharmaceutical therapy.

Key facts

Study ID
NCT06389097
Run by
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
People needed
80
Starts
2025-02-03
Expected to finish
2029-08-01
Last updated by the study team
2026-03-30

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.